Filing Details
- Accession Number:
- 0001209191-14-075121
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-12 20:01:09
- Reporting Period:
- 2014-12-10
- Filing Date:
- 2014-12-12
- Accepted Time:
- 2014-12-12 20:01:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1114220 | Keryx Biopharmaceuticals Inc | KERX | Pharmaceutical Preparations (2834) | 134087132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1434718 | Iii F James Oliviero | C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue New York NY 10022 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock (Exercise Of Stock Options) | Acquisiton | 2014-12-10 | 25,000 | $11.22 | 178,345 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-12-10 | 25,000 | $15.69 | 153,345 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Footnotes
- Reflects the exercise and sale of 25,000 stock options which were due to expire on January 2, 2015 (10 years following their grant date).
- Includes 39,033 shares of restricted stock. In addition, Mr. Oliviero holds 251,639 stock options.
- Reflects the weighted average sale price. The range of prices for such transaction is $15.42 to $16.06.
Billionaire Hedge Funds
